北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 基础医学院  > 病理学系  > 期刊论文
学科主题: 基础医学
题名:
Defective expression of Protein 4.1N is correlated to tumor progression, aggressive behaviors and chemotherapy resistance in epithelial ovarian cancer
作者: Xi, Chenguang1; Ren, Caixia2; Hu, Ajin1; Lin, Jie3; Yao, Qian4; Wang, Yue1; Gao, Zifen1; An, Xiuli5,6; Liu, Congrong1,7
关键词: Protein 4.1N ; Epithelial ovarian cancer ; Tumor progression
刊名: GYNECOLOGIC ONCOLOGY
发表日期: 2013-12-01
DOI: 10.1016/j.ygyno.2013.08.015
卷: 131, 期:3, 页:764-771
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Oncology ; Obstetrics & Gynecology
研究领域[WOS]: Oncology ; Obstetrics & Gynecology
关键词[WOS]: PROSTATE-CANCER ; SUPPRESSOR DAL-1/4.1B ; MEMBRANE ; CELLS ; MOUSE ; GENE ; METHYLATION ; METASTASIS ; CARCINOMA ; FAMILY
英文摘要:

Objective. Protein 4.1N (4.1N) is a member of the Protein 4.1 family that is involved in cellular processes such as cell adhesion, migration and signaling. In this study, we evaluated the expression of 4.1N protein and its potential roles in epithelial ovarian cancer (EOC) tumorigenesis and progression.

Methods. 4.1N protein expression was investigated in a total of 280 samples including 74 normal tissues, 35 benign, 30 borderline and 141 malignant epithelial ovarian tumors by immunohistochemistry. Correlation between 4.1N expression levels and clinicopathologic features was statistically analyzed. The expression of 4.1N in EOC cell lines was examined by western blotting.

Results. Immunohistochemistry analysis revealed that, although there was no loss of 4.1N expression in normal tissues and benign tumors, absence of Protein 4.1N was significantly more common in EOCs (44.0%) than in borderline tumors (3.3%) (p < 0.001). Furthermore, loss or decreased expression of 4.1N protein expression was correlated with malignant potential of the tumors (14.3% in benign tumors, 56.7% in borderline tumors and 92.9% in malignancy) (p < 0.001). In EOC samples, loss of 4.1N protein was significantly associated with advanced-stage (p = 0.004), ascites (p = 0.009), omental metastasis (p = 0.018), suboptimal debulking (p = 0.024), poorly histological differentiation (p = 0.009), high-grade serous carcinoma (p = 0.001), short progression-free-survival (p = 0.018) and poor chemosensitivity to first-line chemotherapy (p = 0.029). Moreover, western blotting analysis revealed that expression of 4.1N protein Was lost in 4/8 (50%) EOC cell lines.

Conclusions. 4.1N protein expression level was significantly decreased during malignant transformation of epithelial ovarian tumors and that loss of 4.1N expression was closely correlated to poorly differentiated and biologically aggressive EOCs. (C) 2013 Elsevier Inc. All rights reserved.

语种: 英语
所属项目编号: 7082055 ; 2009CB521805 ; (2008)890
项目资助者: Beijing Municipal Natural Science Foundation of China ; National Basic Research Program of China (973 Program) ; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry
WOS记录号: WOS:000327923400048
Citation statistics:
内容类型: 期刊论文
版本: 出版稿
URI标识: http://ir.bjmu.edu.cn/handle/400002259/64910
Appears in Collections:基础医学院_病理学系_期刊论文

Files in This Item:
File Name/ File Size Content Type Version Access License
Defective expression of Protein 4.1N is correlated to tumor progression, aggressive behaviors and chemotherapy resistance in epithelial ovarian cancer.pdf(1306KB)期刊论文出版稿限制开放 联系获取全文

作者单位: 1.Peking Univ, Hlth Sci Ctr, Dept Pathol, Beijing 100191, Peoples R China
2.Peking Univ, Hlth Sci Ctr, Dept Histol & Embryol, Beijing 100191, Peoples R China
3.China Japan Friendship Hosp, Dept Pathol, Beijing 100029, Peoples R China
4.Capital Med Univ, Beijing Tongren Hosp, Dept Pathol, Beijing 100005, Peoples R China
5.New York Blood Ctr, Red Cell Physiol Lab, New York, NY 10055 USA
6.Zhengzhou Univ, Dept Bioengn, Zhengzhou 450051, Peoples R China
7.Peking Univ, Hosp 3, Dept Pathol, Beijing 100191, Peoples R China

Recommended Citation:
Xi, Chenguang,Ren, Caixia,Hu, Ajin,et al. Defective expression of Protein 4.1N is correlated to tumor progression, aggressive behaviors and chemotherapy resistance in epithelial ovarian cancer[J]. GYNECOLOGIC ONCOLOGY,2013,131(3):764-771.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Xi, Chenguang]'s Articles
[Ren, Caixia]'s Articles
[Hu, Ajin]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Xi, Chenguang]‘s Articles
[Ren, Caixia]‘s Articles
[Hu, Ajin]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace